factor IX
Showing 1 - 25 of >10,000
Hemophilia A Trial in Metairie, New Orleans (Factor IX)
Recruiting
- Hemophilia A
- Factor IX
-
Metairie, Louisiana
- +1 more
Nov 14, 2022
Hemophilia B Trial in Pune (RIXUBIS: On-Demand, RIXUBIS: Prophylaxis)
Completed
- Hemophilia B
- RIXUBIS: On-Demand
- RIXUBIS: Prophylaxis
-
Pune, Maharashtra, IndiaSahyadri Super Speciality Hospital
Aug 4, 2022
Characterize Effectiveness and Safety of HEMGENIX® in Hemophilia
Not yet recruiting
- Hemophilia B
- HEMGENIX
- Factor IX (FIX)
- (no location specified)
Aug 23, 2023
Hemophilia B Adult Male Participants Receiving Prophylaxis With
Not yet recruiting
- Hemophilia B
- Non-Interventional
- (no location specified)
Oct 4, 2022
Hemophilia B Trial in Johannesburg (Coagulation Factor IX variant)
Completed
- Hemophilia B
- Coagulation Factor IX variant
-
Johannesburg, South AfricaHaemophilia Comprehensive Care Centre
Aug 6, 2021
Hemophilia B Trial in United States (AAV5-hFIXco-Padua (AMT-061))
Active, not recruiting
- Hemophilia B
- AAV5-hFIXco-Padua (AMT-061)
-
Los Angeles, California
- +3 more
May 17, 2022
Hemophilia Trial (Coagulation Factor VIIa (Recombinant))
Not yet recruiting
- Hemophilia
- Coagulation Factor VIIa (Recombinant)
- (no location specified)
Jan 12, 2023
Natural History Study of Factor IX Treatment and Complications
Active, not recruiting
- Factor IX Deficiency
- Standard care with blood and urine sample collection
-
Indianapolis, IndianaIndiana Hemophilia & Thrombosis Center
May 20, 2021
Hemophilia B Trial in Washington (SB-FIX)
Terminated
- Hemophilia B
- SB-FIX
-
Washington, District of ColumbiaGeorgetown University Medical Center
Mar 8, 2022
Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B
Active, not recruiting
- Hemophilia B
- AAV5-hFIX
-
Berlin, Germany
- +5 more
Jan 17, 2023
Hemophilia B Trial in United States (AskBio009)
Active, not recruiting
- Hemophilia B
- AskBio009
-
Los Angeles, California
- +14 more
Feb 18, 2022
Hemophilia Trial in Orange (Fitusiran, Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin concentrate
Recruiting
- Hemophilia
- Fitusiran
- +2 more
-
Orange, CaliforniaCenter for Inherited Blood Disorders (CIBD)-Site Number:8400012
Feb 2, 2023
Hemophilia B Trial in Los Angeles (verbrinacogene setparvovec)
Recruiting
- Hemophilia B
- verbrinacogene setparvovec
-
Los Angeles, CaliforniaChildren's Hospital of Los Angeles
Jan 7, 2022
Hemophilia Trial in Taipei (Albutrepenonacog Alfa 1 UNT [IDELVION])
Recruiting
- Hemophilia
- Albutrepenonacog Alfa 1 UNT [IDELVION]
-
Taipei, TaiwanNational Taiwan University Hospital
Oct 28, 2020
DTX101 (AAVrh10FIX) in Moderate/Severe to Severe Hemophilia B
Completed
- Hemophilia B
-
Little Rock, Arkansas
- +4 more
Jan 4, 2022
Hemophilia B Trial in Worldwide (AAV5-hFIXco-Padua)
Active, not recruiting
- Hemophilia B
- AAV5-hFIXco-Padua
- Factor IX (FIX)
-
Phoenix, Arizona
- +32 more
Sep 26, 2022
Hemophilia Trial in Worldwide (Coagulation Factor VIIa (Recombinant))
Completed
- Hemophilia
- Coagulation Factor VIIa (Recombinant)
-
Dallas, Texas
- +8 more
Feb 24, 2022